Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ALGN Align Technology	$142.43 -0.3%	$179.19	$127.70 ▼ $262.87	$10.32B	1.61	2.44 million shs	1.11 million shs
BSX Boston Scientific	$103.15 -1.0%	$103.56	$77.29 ▼ $108.94	$152.87B	0.66	6.96 million shs	5.34 million shs
HOLX Hologic	$67.81 -0.4%	$65.60	$51.90 ▼ $84.39	$15.08B	0.49	1.74 million shs	4.29 million shs
HQY HealthEquity	$89.89 +2.8%	$98.42	$72.79 ▼ $116.65	$7.77B	0.54	838,496 shs	894,425 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ALGN Align Technology	0.00%	+1.82%	-25.92%	-24.36%	-35.27%
BSX Boston Scientific	0.00%	-0.07%	-1.41%	-2.69%	+34.98%
HOLX Hologic	0.00%	-0.37%	+5.92%	+19.40%	-16.27%
HQY HealthEquity	0.00%	-3.40%	-10.22%	-8.49%	+26.32%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ALGN Align Technology	4.9471 of 5 stars	4.3	3.0	3.8	3.5	3.3	2.5
BSX Boston Scientific	4.7352 of 5 stars	3.5	5.0	4.2	3.0	2.5	1.3
HOLX Hologic	4.8555 of 5 stars	3.3	5.0	4.3	3.6	1.7	2.5
HQY HealthEquity	4.3288 of 5 stars	4.5	3.0	0.0	3.6	2.5	1.9

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ALGN Align Technology	2.60	Moderate Buy	$215.00	50.95% Upside
BSX Boston Scientific	3.04	Buy	$117.50	13.91% Upside
HOLX Hologic	2.53	Moderate Buy	$77.83	14.78% Upside
HQY HealthEquity	3.00	Buy	$118.55	31.88% Upside

Current Analyst Ratings Breakdown

Latest BSX, ALGN, HOLX, and HQY Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/6/2025	HOLX Hologic	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Sector Perform ➝ Outperform	$72.00 ➝ $87.00
7/31/2025	HOLX Hologic	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$75.00
7/31/2025	ALGN Align Technology	Mizuho Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$210.00
7/31/2025	ALGN Align Technology	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$246.00 ➝ $199.00
7/31/2025	ALGN Align Technology	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$275.00 ➝ $200.00
7/31/2025	ALGN Align Technology	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$250.00 ➝ $190.00
7/31/2025	ALGN Align Technology	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Equal Weight	$249.00 ➝ $154.00
7/31/2025	HOLX Hologic	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Equal Weight ➝ Equal Weight	$65.00 ➝ $69.00
7/31/2025	HOLX Hologic	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Neutral ➝ Neutral	$65.00 ➝ $70.00
7/24/2025	BSX Boston Scientific	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform ➝ Outperform
7/24/2025	BSX Boston Scientific	Raymond James Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Strong-Buy ➝ Strong-Buy	$121.00 ➝ $124.00

(Data available from 8/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ALGN Align Technology	$3.96B	2.60	$8.99 per share	15.85	$53.98 per share	2.64
BSX Boston Scientific	$16.75B	9.13	$3.65 per share	28.26	$15.29 per share	6.75
HOLX Hologic	$4.03B	3.74	$5.50 per share	12.33	$21.77 per share	3.11
HQY HealthEquity	$1.24B	6.25	$4.26 per share	21.08	$24.40 per share	3.68

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ALGN Align Technology	$421.36M	$5.93	24.02	15.91	1.61	11.04%	13.36%	8.32%	10/22/2025 (Estimated)
BSX Boston Scientific	$1.85B	$1.68	61.40	31.93	2.48	13.55%	19.21%	10.62%	10/22/2025 (Estimated)
HOLX Hologic	$789.50M	$2.41	28.14	14.68	2.46	13.79%	19.69%	10.82%	11/3/2025 (Estimated)
HQY HealthEquity	$96.70M	$1.37	65.61	31.65	1.39	9.80%	11.01%	6.77%	9/2/2025 (Estimated)

Latest BSX, ALGN, HOLX, and HQY Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
9/2/2025	Q2 2026	HQY HealthEquity	$0.92	N/A	N/A	N/A	$320.68 million	N/A
7/30/2025	Q2 2025	ALGN Align Technology	$2.57	$2.49	-$0.08	$1.72	$1.06 billion	$1.01 billion
7/30/2025	Q3 2025	HOLX Hologic	$1.05	$1.08	+$0.03	$0.86	$1.01 billion	$1.02 billion
7/23/2025	Q2 2025	BSX Boston Scientific	$0.72	$0.75	+$0.03	$0.53	$4.89 billion	$5.06 billion
6/3/2025	Q1 2026	HQY HealthEquity	$0.81	$0.97	+$0.16	$0.61	$322.25 million	$330.80 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ALGN Align Technology	N/A	N/A	N/A	N/A	N/A
BSX Boston Scientific	N/A	N/A	N/A	N/A	N/A
HOLX Hologic	N/A	N/A	N/A	N/A	N/A
HQY HealthEquity	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ALGN Align Technology	N/A	1.23	1.10
BSX Boston Scientific	0.49	1.37	0.82
HOLX Hologic	0.52	3.55	2.81
HQY HealthEquity	0.50	4.06	4.06

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ALGN Align Technology	88.43%
BSX Boston Scientific	89.07%
HOLX Hologic	94.73%
HQY HealthEquity	99.55%

Insider Ownership

Company	Insider Ownership
ALGN Align Technology	0.66%
BSX Boston Scientific	0.50%
HOLX Hologic	1.88%
HQY HealthEquity	1.50%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ALGN Align Technology	20,945	72.49 million	72.01 million	Optionable
BSX Boston Scientific	53,000	1.48 billion	1.47 billion	Optionable
HOLX Hologic	7,063	222.42 million	218.24 million	Optionable
HQY HealthEquity	3,120	86.48 million	85.18 million	Optionable

BSX, ALGN, HOLX, and HQY Headlines

Recent News About These Companies

Deutsche Bank AG Lowers Holdings in HealthEquity, Inc. (NASDAQ:HQY)

August 17 at 3:43 AM | marketbeat.com

Nuveen LLC Acquires New Holdings in HealthEquity, Inc. (NASDAQ:HQY)

August 16 at 4:28 AM | marketbeat.com

HealthEquity, Inc. (NASDAQ:HQY) Position Lowered by Connor Clark & Lunn Investment Management Ltd.

August 16 at 4:04 AM | marketbeat.com

Invesco Ltd. Acquires 821,425 Shares of HealthEquity, Inc. (NASDAQ:HQY)

August 15 at 4:50 AM | marketbeat.com

Citigroup Inc. Increases Stake in HealthEquity, Inc. (NASDAQ:HQY)

August 15 at 4:12 AM | marketbeat.com

Swiss National Bank Has $14.84 Million Holdings in HealthEquity, Inc. (NASDAQ:HQY)

August 15 at 4:02 AM | marketbeat.com

Reasons to Hold HealthEquity Stock in Your Portfolio for Now

August 14 at 12:06 PM | zacks.com

15,300 Shares in HealthEquity, Inc. (NASDAQ:HQY) Acquired by Montanaro Asset Management Ltd

August 14 at 6:15 AM | marketbeat.com

Charles Schwab Investment Management Inc. Boosts Stake in HealthEquity, Inc. (NASDAQ:HQY)

August 14 at 3:48 AM | marketbeat.com

Vanguard Group Inc. Lowers Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

August 14 at 3:38 AM | marketbeat.com

HealthEquity Community Foundation Expands National Impact with $50,000 in Grants

August 13, 2025 | finance.yahoo.com

CORRECTION - HealthEquity Community Foundation Expands National Impact with $50,000 in Grants

August 12, 2025 | globenewswire.com

Motley Fool Asset Management LLC Sells 4,183 Shares of HealthEquity, Inc. (NASDAQ:HQY)

August 12, 2025 | marketbeat.com

Motley Fool Wealth Management LLC Sells 11,262 Shares of HealthEquity, Inc. (NASDAQ:HQY)

August 12, 2025 | marketbeat.com

PNC Financial Services Group Inc. Purchases 4,183 Shares of HealthEquity, Inc. (NASDAQ:HQY)

August 12, 2025 | marketbeat.com

Zions Bancorporation National Association UT Invests $1.99 Million in HealthEquity, Inc. (NASDAQ:HQY)

August 10, 2025 | marketbeat.com

Ontario Teachers Pension Plan Board Makes New Investment in HealthEquity, Inc. (NASDAQ:HQY)

August 10, 2025 | marketbeat.com

NBW Capital LLC Has $4.59 Million Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

August 9, 2025 | marketbeat.com

OGN vs. HQY: Which Stock Is the Better Value Option?

August 8, 2025 | zacks.com

New Age Alpha Advisors LLC Buys 19,584 Shares of HealthEquity, Inc. (NASDAQ:HQY)

August 8, 2025 | marketbeat.com

Contrasting HealthEquity (NASDAQ:HQY) & So-Young International (NASDAQ:SY)

August 8, 2025 | americanbankingnews.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BSX, ALGN, HOLX, and HQY Company Descriptions

Align Technology NASDAQ:ALGN

$142.43 -0.45 (-0.31%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$142.70 +0.27 (+0.19%)

As of 08/15/2025 07:55 PM Eastern

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Boston Scientific NYSE:BSX

$103.15 -1.00 (-0.96%)

Closing price 08/15/2025 03:59 PM Eastern

Extended Trading

$103.37 +0.22 (+0.21%)

As of 08/15/2025 07:58 PM Eastern

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

Hologic NASDAQ:HOLX

$67.81 -0.25 (-0.37%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$68.39 +0.58 (+0.85%)

As of 08/15/2025 05:46 PM Eastern

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, specimen radiology, and connectivity solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, the company offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

HealthEquity NASDAQ:HQY

$89.89 +2.46 (+2.81%)

Closing price 08/15/2025 04:00 PM Eastern

Extended Trading

$89.63 -0.26 (-0.29%)

As of 08/15/2025 05:49 PM Eastern

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. HealthEquity, Inc. was incorporated in 2002 and is based in Draper, Utah.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time